Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87.4M
Number of holders
21
Total 13F shares, excl. options
21.1M
Shares change
+19.7M
Total reported value, excl. options
$200M
Value change
+$186M
Number of buys
18
Number of sells
-1
Price
$9.75

Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q4 2021

22 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21.1M shares of 87.4M outstanding shares and own 24.15% of the company stock.
Largest 10 shareholders include FMR LLC (12M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.3M shares), Redmile Group, LLC (2.5M shares), Velan Capital Investment Management LP (600K shares), Parian Global Management LP (467K shares), VANGUARD GROUP INC (442K shares), Hongkou Capital LP (400K shares), Saba Capital Management, L.P. (400K shares), Alpine Global Management, LLC (385K shares), and CVI Holdings, LLC (200K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.